Effect of targeting mitogen-activated protein kinase on cardiac remodeling in rats

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 14, Issue 4, 2009, Pages 339-346

  Baraka, Azza ^a   Mikhail, Maher ^a   Guemei, Aida ^a   El Ghotny, Samar ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Hypertrophy; MAPK; Remodeling; Retinoic acid; Rosuvastatin; Statins

Indexed keywords

CASPASE 3; HYDROXYPROLINE; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; RETINOIC ACID; ROSUVASTATIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; HEART PAPILLARY MUSCLE; HEART VENTRICLE REMODELING; MEAN ARTERIAL PRESSURE; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT; SYNTHESIS;

ANIMALS; BLOOD PRESSURE; CASPASE 3; DRUG DELIVERY SYSTEMS; FLUOROBENZENES; HEART VENTRICLES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYDROXYPROLINE; MALE; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PAPILLARY MUSCLES; PYRIMIDINES; RANDOM ALLOCATION; RATS; SULFONAMIDES; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 70449644543     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248409349620     Document Type: Article

References (40)

1. Myerson SG, Montgomery HE, Whittingham M., et al. Left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism. Circulation. 2000 ; 103: 226-230.
2. Raizada MK, Paton JF Recent advances in the renin-angiotensin system: angiotensin-converting enzyme 2 and (pro)renin receptor. Exp Physiol. 2008 ; 93 (5). 517-518.
3. See F., Thomas W., Way K., et al. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J Am Coll Cardiol. 2004 ; 44 (8). 1679-1689.
4. Thornton TM, Rincon M. Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci. 2009 ; 5 (1). 44-51.
5. Li M., Georgakopoulos D., Lu G., et al. p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation. 2005 ; 111 (19). 2494-2502.
6. Dechow C., Morath C., Peters J., et al. Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis. Am J Physiol Renal Physiol. 2001 ; 281: F909 - F919.
7. Maier LS Vitamin A for the heart: progress for cardiac hypertrophy regression? Am J Physiol Heart Circ Physiol. 2008 ; 294 (2). H633 - H644.
8. Xu Q., Konta T., Furusu A., et al. Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect. J Biol Chem. 2002 ; 277 (44). 41693-41700.
9. Tristano AG, Castejon AM, Castro A., Cubeddu LX Effects of statin treatment and withdrawal on angiotensin II-induced phosphorylation of p38 MAPK and ERK1/2 in cultured vascular smooth muscle cells. Biochem Biophysic Res Commun. 2007 ; 353 (1). 11-17.
10. Pechanova O., Bernatova I., Pelouch V., Babal P. L-NAME-induced protein remodeling and fibrosis in the rat heart. Physiol Res. 1999 ; 48 (5). 353-362.
11. Bernatova I., Pechanova O., Simko F. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp Physiol. 1999 ; 84 (6). 1095-1105.
12. Gianella A., Nobili E., Abbate M., et al. Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats. Am J Pathol. 2007 ; 170 (4). 1165-1177.
13. Qin Y., Zhou A., Ben X., Shen J., Liang Y., Li F. All-trans retinoic acid in pulmonary vascular structural remodeling in rats with pulmonary hypertension induced by monocrotaline. Chin Med J (Engl). 2001 ; 114 (5). 462-465.
14. Pu Q., Neves MF, Virdis A., Touyz RM, Schiffrin EL Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension. 2003 ; 42 (1). 49-55.
15. Bing OH, Wiegner AW, Brooks WW, Fishbein MC, Pfeffer JM Papillary muscles structure function relations in the aging spontaneously hypertensive rat. Clin Exp Hypertens. 1988 ; 10 (1). 37-58.
16. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961 ; 93: 440-447.
17. Harper SJ, LoGrasso P. Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal. 2001 ; 13 (5). 299-310.
18. Ramesh G., Reeves WB TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 2002 ; 110 (6). 835-842.
19. Kaushal GP, Singh AB, Shah SV Identification of gene family of caspases in rat kidney and altered expression in ischemia reperfusion injury. Am J Physiol Renal Physiol. 1998 ; 274 (3 pt 2). F587 - F595.
20. Winer BJ Statistical Principles in Experimental Design. 2 nd ed. New York: McGraw-Hill ; 1971.
21. Cardiac plasticity. N Engl J Med. 2008 ; 358 (13). 1370-1380.
22. Mann DL Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu Rev Physiol. 2003 ; 65: 81-101.
23. Li M., Georgakopoulos D., Lu G., et al. p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation. 2005 ; 111 (19). 2494-2502.
24. Kompa AR, See F., Lewis DA, et al. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction. J Pharmacol Exp Ther. 2008 ; 325 (3). 741-750.
25. Janicki JS, Brower GL The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail. 2002 ; 8 (6 suppl). S319 - S325.
26. Engel D., Peshock R., Armstong RC, Sivasubramanian N., Mann DL Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. Am J Physiol Heart Circ Physiol. 2004 ; 287 (3). H1303 - H1311.
27. Tristano AG, Castejon AM, Castro A., Cubeddu LX Effects of statin treatment and withdrawal on angiotensin II-induced phosphorylation of p38 MAPK and ERK1/2 in cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 2007 ; 353 (1). 11-17.
28. Dechend R., Fiebeler A., Park JK, et al. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Circulation. 2001 ; 104 (5). 576-581.
29. Rombouts K., Kisanga E., Hellemans K., Wielant A., Schuppan D., Geerts A. Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. J Hepatol. 2003 ; 38 (5). 564-572.
30. Mattingly RR, Gibbs RA, Menard RE, Reiners JJ Jr. Potent suppression of proliferation of a10 vascular smooth muscle cells by combined treatment with lovastatin and 3-allylfarnesol, an inhibitor of protein farnesyltransferase. J Pharmacol Exp Ther. 2002 ; 303 (1). 74-81.
31. Wassmann S., Laufs U., Muller K., et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2002 ; 22 (2). 300-305.
32. Ni W., Egashira K., Kataoka C., et al. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis. Circ Res. 2001 ; 89 (5). 415-421.
33. Franzoni F., Quinones-Galvan A., Regoli F., Ferrannini E., Galetta F. A comparative study of the in vitro antioxidant activity of statins. Int J Cardiol. 2003 ; 90 (2-3). 317-321.
34. Wang HJ, Zhu YC, Yao T. Effects of all-trans retinoic acid on angiotensin II-induced myocyte hypertrophy. J Appl Physiol. 2002 ; 92 (5). 2162-2168.
35. Wu JM, Garami M., Cheng T., Gardner DG 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest. 1996 ; 97 (7). 1577-1588.
36. Lu L., Yao T., Zhu YZ, Huang GY, Cao YX, Zhu YC Chronic all-trans retinoic acid treatment prevents medial thickening of intramyocardial and intrarenal arteries in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2003 ; 285 (4). H1370 - H1377.
37. Choudhary R., Palm-Leis A., Scott RC 3rd, et al. All-trans retinoic acid prevents development of cardiac remodeling in aortic banded rats by inhibiting the renin-angiotensin system. Am J Physiol Heart Circ Physiol. 2008 ; 294 (2). H633 - H644.
38. Palm-Leis A., Singh US, Herbelin BS, Olsovsky GD, Baker KM, Pan J. Mitogen-activated protein kinases and mitogen-activated protein kinase phosphatases mediate the inhibitory effects of all-trans retinoic acid on the hypertrophic growth of cardiomyocytes. J Biol Chem. 2004 ; 279 (52). 54905-54917.
39. Zhong JC, Huang DY, Yang YM, et al. Upregulation of angiotensin- converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension. 2004 ; 44 (6). 907-912.
40. Zhong JC, Huang DY, Liu GF, et al. Effects of all-trans retinoic acid on orphan receptor APJ signaling in spontaneously hypertensive rats. Cardiovasc Res. 2005 ; 65 (3). 743-750.